Spectrophotometric determination of azathioprine in pharmaceutical formulations

Four simple and sensitive visible spectrophotometric methods (A–D) have been described for the assay of azathioprine (ATP) either in pure form or in pharmaceutical formulations. Methods A and B are based on the oxidation of ATP with excess N-bromosuccinimide (NBS) or chloramine-T (CAT) and determining the consumed NBS or CAT with a decrease in colour intensity of celestine blue (CB) (method A) or gallocyanine (GC) (method B), respectively. Methods C and D are based on the diazotisation of reduced azathioprine (RATP) with excess nitrous acid and estimating either the consumed nitrous acid (HNO₂) with cresyl fast violet acetate (CFVA) (method C) or by coupling reaction of the diazonium salt formed with N-1-naphthyl ethylene diamine dihydrochloride (NED) (method D). All of the variables have been optimized and the reactions presented. The concentration measurements are reproducible within a relative standard deviation of 1.0%. Recoveries are 99.2–100.3%.     

Spectrophotometric procedures for the determination of roxithromycin in pharmaceutical formulations

Four simple and sensitive visible spectrophotometric procedures for the assay of roxithromycin (RXT) have been developed. Procedures A and B are based on the formation of ion-pairs of roxithromycin with the dyes supracen violet 3B and tropaeolin 000, which are extracted into chloroform and have absorption maxima at 590 nm (SV 3B) and 490 nm (TP 000). Procedures C and D are based on condensation between the hydrolysis product of RXT in the presence of 3.6M hydrochloric acid in acetic acid medium and vanillin orp-dimethylaminobenzaldehyde (PDAB) to form coloured products with _max at 500 nm. Regression analysis of the Beer's plot showed good correlation in the concentration ranges 5–60 (A), 5–40 (B) and 5–50 (C & D) g/ml. No interference was observed from excipients and the validity of the procedures was tested by analysing pharmaceutical formulations. Recoveries were 99.0–102.0%. The concentration measurements are reproducible within a relative standard deviation of 1.0%.     

Spectrophotometric determination of etodolac in pure form and pharmaceutical formulations

Background

A routine method for the quantification of beryllium in biological fluids is essential for the development of a chelation therapy for Chronic Beryllium Disease (CBD). We describe a procedure for the direct determination of beryllium in undigested micro quantities of human blood and serum using graphite furnace atomic absorption spectrometry. Blood and serum samples are prepared respectively by a simple 8-fold and 5-fold dilution with a Nash Reagent. Three experimental setups are compared: using no modifier, using magnesium nitrate and using palladium/citric acid as chemical modifiers.

Results

In serum, both modifiers did not improve the method sensitivity, the optimal pyrolysis and atomization temperatures are 1000°C and 2900°C, respectively. In blood, 6 μg of magnesium nitrate was found to improve the method sensitivity. The optimal pyrolysis and atomization temperatures were 800°C and 2800°C respectively.

Conclusion

In serum, the method detection limit was 2 ng l^-1, the characteristic mass was 0.22 (± 0.07) pg and the accuracy ranged from 95 to 100%. In blood, the detection limit was 7 ng l^-1, the characteristic mass was 0.20 (± 0.02) pg and the accuracy ranged from 99 to 101%.     

Spectrophotometric determination of drugs in pharmaceutical formulations withN-bromosuccinimide and celestine blue

Simple, sensitive and selective methods are proposed for the spectrophotometric determination of drugs, viz., tetracycline HCl, nifurtimox, ethionamide, propranolol HCl and isonicotinic acid hydrazide, based on their reactivity withN-bromosuccinimide (NBS). The method involves the addition of excess NBS of known concentration in the presence of 0.25M HCl and the unreacted NBS is determined by the measurement of the decrease in the absorbance of the dye celestine blue (_max 540 nm), which was found to be the most suitable of several dyes tested. This method was applied for the determination of drug contents in pharamaceutical formulations and enabled the determination of the drugs in microgram quantities (0.2 to 5 g/ml). Standard deviations were typically 0.5mg per dose (RSD 0.1–1.0%). No interferences were observed from excipients and the validity of the method was tested against reference method. Recoveries were 99.8–101.1%.     

Spectrophotometric determination of certain cephalosporins in pure form and in pharmaceutical formulations

A simple and reproducible spectrophotometeric method for the assay of cefotaxime sodium, cefuroxime sodium, and ceftriaxone disodium with metol-chromium(VI) reagent has been developed. The procedure is based on direct oxidation of metol by potassium dichromate in presence of drug in acidic medium and subsequent formation of ternary complex. Beer's law is obeyed in the range 0.2-28 microg ml(-1) at lambdamax 520 nm. For more accurate analysis, Ringbom optimum concentration range is found to be 0.8-26.5 microg ml(-1). The molar absorptivity and Sandell sensitivity were calculated. Six replicate analysis of solutions containing seven different concentrations of the examined drugs were carried out and gave a mean correlation coefficient < or =0.9996; the factors of the regression line equation for the three cephalosporins were calculated. The proposed method was applied to the determination of the examined drugs in pharmaceutical formulations and the results demonstrated that the method is equally accurate, precise, and reproducible as the official methods.     

Spectrophotometric determination of pipazethate hydrochloride in pure form and in pharmaceutical formulations

Three simple, sensitive, and reproducible spectrophotometric methods (A-C) for the determination of pipazethate hydrochloride (PiCl) in pure form and in pharmaceutical formulations are described. The first and second methods, A and B, are based on the oxidation of the drug by Fe3+ in the presence of o-phenanthroline (o-phen) or bipyridyl (bipy). The formation of tris-complex upon reactions with Fe3+-o-phen and/or Fe3+-bipy mixture in an acetate buffer solution of the optimum pH values was demonstrated at 510 and 522 nm, respectively, with o-phen and bipy. The third method, C, is based on the reduction of Fe(III) by PiCl in acid medium and subsequent interaction of Fe(II) with ferricyanide to form Prussian blue, which exhibits an absorption maximum at 750 nm. The concentration ranges are from 0.5 to 8, 2 to 16, and 3 to 15 microg/mL for Methods A-C, respectively. For more accurate analysis, Ringbom optimum concentration ranges were calculated. The molar absorptivity, Sandell sensitivity, and detection and quantitation limits were calculated. The developed methods were successfully applied to the determination of PiCl in bulk and pharmaceutical formulations without any interference from common excipients. The relative standard deviations were < or =0.83% with recoveries of 98.9-101.15%.     

Spectrophotometric methods for the determination of omeprazole in bulk form and pharmaceutical formulations

Four simple and sensitive methods for the assay of omeprazole (OMZ) were developed. These methods are based on the formation of colored species by treating OMZ with 3-methyl-2-benzothiazolinone hydrazone (MBTH) following oxidation with ferric chloride (method A) or m-aminophenol following oxidation with chloramine-T (CAT) (method B) or Folin-Ciocalteau reagent (FC) (method D), or by oxidizing OMZ with excess N-bromosuccinimide (NBS) and determining the consumed NBS with a decrease in color intensity of Celestine blue (CB) (method C). All variables have been optimized. Regression analysis of Beer's plots showed good correlation in the concentration range of 1.0-10, 2.0-32, 0.4-2.4 and 0.8-10 mug ml(-1) for methods A, B, C and D, respectively. No interference was observed for formulation additives and the validity of each method was tested by analysing capsules containing OMZ. Recoveries were 98.7-100.1%.     

Spectrophotometric methods for the determination of nifurtimox in bulk form and pharmaceutical formulations

Three simple and sensitive methods for the assay of Nifurtimox (NIF) which is an active antitrypanocide were developed. These methods are based on the formation of coloured species by treating either its reduction product with 3-methyl-2-benzothiazolinone hydrazone (MBTH) in the presence of ferric chloride (method A) or its hydrolysis product with 2-thiobarbituric acid (TBA) (method B) or by oxidizing it with excess N-bromosuccinamide (NBS) and determining the consumed NBS using p-N-methylaminophenol sulphate (metol)-isonicotinic acid hydrazide (INH) (method C). All variables have been optimized and the reaction mechanisms presented. Regression analysis of Beer's plot showed good correlation in the concentration range of 2.5-10, 2.5-30 and 1.25-7.5 microg/ml for methods A, B and C, respectively. No interference was observed from the additives and the validity of the methods was tested by analysing the tablets. Recoveries were 99.2-100.9%.     

Spectrophotometric estimation of ketotifen fumarate in pharmaceutical formulations

Four simple and sensitive spectrophotometric methods (A–D) for the determination of Ketotifen fumarate in bulk samples and pharmaceutical formulations are described. They are based on the formation of coloured species by the coupling of the diazotised sulphanilamide with the drug (method A, _max 520 nm) or by oxidizing it with excessN-bromo-succinimide and determining the consumed NBS with decrease in colour intensity of celestine blue (method B: _max 540 nm) or by the reduction of Folin-Ciocalteau reagent (method C: _max 720 nm) or by the formation of a chloroform-soluble, coloured ionassociation complex between the drug and Azocarmine G at pH 1.5 (method D: _max 540 nm). Regression analysis of Beer-Lambert plots showed good correlations in the concentration ranges 1–10, 2–12, 4–28 and 2.5–25 g/ml for methods A–D, respectively. The validity of the proposed methods was tested by analysing pharmaceutical formulations containing KTF: the relative standard deviations were within ±1.0%. Recoveries were 98.9–100.2%.     

Spectrophotometric determination of hyoscine butylbromide and famciclovir in pure form and in pharmaceutical formulations

A simple, rapid, and extractive spectrophotometric method was developed for the determination of hyoscine butylbromide (HBB) and famciclovir (FCV) in pure and pharmaceutical formulations. These methods are based on the formation of yellow ion-pair complexes between the basic nitrogen of the drug and four sulphonphthalein acid dyes, namely; bromocresol green (BCG), bromothymol blue (BTB), bromocresol purple (BCP) and bromophenol blue (BPB) in phthalate buffer of pH range (3.0-3.5). The formed complexes were extracted with chloroform and measured at 420, 412, 409 and 415nm for HBB and at 418, 412, 407 and 414nm for FCV using BCG, BTB, BCP and BPB, respectively. The analytical parameters and their effects on the reported systems are investigated. Beer's law was obeyed in the range 1.0-20mugmL(-1) with correlation coefficient (n=6)>/=0.9997. The molar absorptivity, Sandell sensitivity, detection and quantification limits were also calculated. The composition of the ion pairs was found 1:1 by Job's method in all cases and the conditional stability constant (K(f)) of the complexes have been calculated. The free energy changes (DeltaG) were determined for all complexes formed. The proposed methods have been applied successfully for the analysis of the studied drugs in pure and pharmaceutical formulations with percentage recoveries ranges from 99.84 to 100.26. The results were in good agreement with those obtained by the official methods.     

分光光度法测定多巴胺

根据多巴胺与亚硝酸钠在pH 5 .90时的反应产物在 30 0nm处有最大吸收 ,建立了测定多巴胺注射液中多巴胺浓度的分光光度法。多巴胺质量浓度在0～ 1 0 μg mL范围内与吸光度之间遵从朗伯比尔定律 ,表观摩尔吸光系数为 1 .85× 1 0 4 L·mol-1·cm-1,检测限为 0 .1 μg mL。试验了pH、放置时间、加热时间、干扰离子等对测定的影响。本法可用于注射液中多巴胺含量的测定 ,与药典规定方法对照 ,结果吻合。     

Spectrophotometric method for quantitative determination of montelukast in bulk,pharmaceutical formulations and human serum

A simple ultraviolet spectrophotometric method for the estimation of montelukast in methanol has been devised and been compared with the existing pharmacopoeial RP-HPLC method for estimation of the drug. The limit of detection of montelukast at 283 nm was 75.2 ng/mL. The calibration was linear in the range of 3–45 μg/mL. Analytical parameters such as stability, selectivity, accuracy and precision have been established for the method in MONAKA® tablets and in human serum and evaluated statistically to assess the application of the method. The method was validated under the ICH and USP guidelines and found to comprise the advantages for simplicity, stability, sensitivity, reproducibility and accuracy for using as an alternate to the existing non-spectrophotometric methods for the routine analysis of the drug in pharmaceutical formulations and in pharmaceutical investigations involving montelukast.     

HPLC determination of clenbuterol in pharmaceutical gel formulations

A quick, accurate, reproducible high performance liquid chromatographic (HPLC) method for the determination of clenbuterol in the presence of some common pharmaceutical preservatives (i.e., methyl and propyl paraben) is described. The method is specific enough to separate and determine clenbuterol in the presence of degradation products of the formulation components. Extraction of interfering formulation components provides the necessary clean-up to determine clenbuterol via HPLC.     

Flow-injection spectrophotometric determination of methyldopa in pharmaceutical formulations

A flow-injection spectrophotometric procedure is proposed for methyldopa determination in pharmaceutical preparations. The determination is based on formation of a yellow product (measured at 410 nm) after complexation of methyldopa with molybdate. Under optimal conditions, Beer's law is obeyed in a concentration range of 50-200 mg l⁻¹ methyldopa. Typical correlation between absorbance and analyte concentration was 0.9999. Usual excipients used as additives in pharmaceuticals do not interfere with the proposed method. The analytical frequency was 210 h⁻¹ and the relative standard deviation (R.S.D.) was ≤2% for sample solution containing 150 mg l⁻¹ methyldopa (n = 11). The analytical results obtained in commercial formulations by applying the proposed FIA method were in good agreement with labeled values and those obtained by the Brazilian Pharmacopoeia procedure at 95% confidence level.     

Spectrophotometric determination of certain antidepressants in pharmaceutical preparations

Simple and reproducible spectrophotometric methods have been developed for determination of sertraline, fluoxetine, and venlafaxine in pharmaceutical preparations. The methods are based on the reactions between the studied drug substances and ion-pair agents (bromothymol blue, bromocresol green, or bromophenol blue) to produce yellow-colored ion-pair complexes in acidic buffers. After extracting in chloroform, the ion-pair complexes are spectrophotometrically determined at the optimum wavelength. Optimizations of the reaction conditions were carried out. Beer's law was obeyed within the concentration range from 1 to 15 microg/mL. The molar absorptivity, Sandell sensitivity, and detection and quantification limits were also determined. The developed methods were applied successfully for the determination of these drugs in some available commercial preparations. The results were compared statistically with those obtained from reported high-performance liquid chromatography methods.     

Spectrophotometric determination of L-ascorbic acid in pharmaceutical preparations

The method is based on the oxidation of L-ascorbic acid with potassium hexacyanoferrate (III). Excess of oxidant is determined spectrophotometrically by oxidation of phthalophenone to phenolphthalein in alkaline solution. Linear calibration graphs are obtained for 0–7 μg ml^?1 ascorbic acid at 553 nm, with a detection limit of 0.1 μg ml^?1. Sugars and other organic compounds do not interfere when present in moderate amounts.     

Spectrophotometric determination of mefenamic acid in pharmaceutical preparations

The present paper describes an effective and low-cost spectrophotometric method for the determination of mefenamic acid in its pure form and pharmaceutical preparations. The method is based on the charge-transfer complexation between mefenamic acid as an n-electron donor and chloranil as a π-acceptor to form a violet chromogen measured at 540 nm. Under the optimum conditions, a linear relationship with a good correlation coefficient (0.9996) was found between the absorbance and concentration of the studied drug in the range of 10–60 μg/mL. The optimal reaction conditions such as reagent concentration, heating time, and stability of the reaction product were determined. The limit of detection (LOD) was 2.16 μg/mL and the limit of quantifycation (LOQ) was 7.15 μg/mL. The method was successfully applied to the determination of mefenamic acid in pharmaceutical preparations without any interference from common excipients. The text was submitted by the author in English.     

Spectrophotometric determination of cysteine andN-acetylcysteine in pharmaceutical preparations

An accurate fast spectrophotometric method for the determination of cysteine andN-acetyl-cysteine is presented, based on the oxidation of these amino acids by ferric ions in the presence of ferrozine, whereby a violet-coloured complex is formed which absorbs at 562 nm. The method was satisfactory for the determination of cysteine andN-acetylcysteine in samples within the range 0.02–6.00 gml^–1. Effects of time, acidity, ferric ions, ferrozine, sodium perchlorate concentrations and the tolerance limit for other amino acids have been reported. The method was applied to the determination of cysteine in amino acids mixtures andN-acetylcysteine in pharmaceutical preparations.